Rice neuroscientists have used a nanosized sensor to record spinal cord neurons in free-moving mice, a feat that could lead to the development of better treatments for spinal cord disease and injury.
Rice and the University of Texas MD Anderson Cancer Center today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
A number of Rice graduate programs are rated among the nation’s best in the latest edition of U.S. News and World Report’s “Best Graduate Schools” rankings.
A research team from Rice University led by Aryeh Warmflash has made strides in understanding the processes that guide human embryonic development. The group’s findings were published in the scientific journal Cells Systems May 15.
Rice University’s Office of Ethics, Compliance and Enterprise Risk hosted the second annual Ethics and Compliance Symposium at Farnsworth Pavilion in the Rice Memorial Center April 23.
A team of Rice researchers and collaborators have developed peptide-based hydrogels that mimic the aligned structure of muscle and nerve tissues, which could enable the development of functional lab-grown tissue.
Team Heartbeat HERoes claimed victory at Rice University’s Oshman Engineering Design Kitchen’s (OEDK) annual Huff OEDK Engineering Design Showcase last month. The team secured the 2024 Woods-Leazar Innovation Award along with a $5,000 cash prize for its project in medical engineering.
Rice professors Pedro Alvarez and Antonios Mikos have been elected fellows of the American Academy of Arts and Sciences, one of the oldest learned societies in the nation.
Nine Rice University faculty members received the 2024 George R. Brown Award for Superior Teaching, which honors top Rice instructors based on votes from alumni who graduated within the past two, three and five years.
Bioengineers at Rice University have been awarded $1.4 million as part of a multi-center consortium funded by the Advanced Research Projects Agency for Health (ARPA-H) to develop strategies for reversing the effects of osteoarthritis.
Rice engineers have developed the smallest implantable brain stimulator demonstrated in a human patient that could revolutionize treatment for drug-resistant depression and other psychiatric or neurological disorders.